Artiva Biotherapeutics, Inc. (ARTV) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Artiva Biotherapeutics, Inc. (ARTV) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Artiva Biotherapeutics, Inc.

· ARTV

Dashboard

Financials

Ratios

Valuation

Statistics

330.181 M

-3.93%

General

Market Cap: $343.7M
Enterprise Value: $44.51M
Shares Outstanding: 48,590,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -24.64%
ROE: -53.86%
ROIC: -26.91%
Current Ratio: 24.16
Debt-to-Equity: 0.03
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.29
P/S: —
P/FCF: —
P/B: 0.97
EV/EBITDA: -0.51

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $95.48M
Operating Income: -$96.15M
Net Profit: -$90.82M

Balance Sheet

Cash and Equivalents: $301.45M
Working Capital: $337.7M
Total Assets: $368.63M
Net Debt: -$291.61M
Total Liabilities: $21.13M
Total Equity: $347.5M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$96.18M
Cash Flow from Investing: $80.54M
Cash Flow from Financing: $282.89M
Free Cash Flow: -$98.1M
Capital Expenditures: $1.92M